Product Information
REPATHA 140 MG/ML SURECLICK is a brand product labeled by Amgen Inc., priced at $282.0209 per ML under NDC 72511076002. Its NADAC has been published 388 times since Jan 23, 2019.
Strength
140 mg/mL
Manufacturer
Amgen Inc.NDC
72511076002
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
EVOLOCUMABApproval Type
Biologic (BLA)
FDA Application
BLA125522On Market Since
10/9/2018
Pharmacological Classes
Price Statistics
The NADAC for REPATHA 140 MG/ML SURECLICK has been published 388 times since Jan 23, 2019, and over the history we have for it it has risen 29.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $282.0209 per ML |
|---|---|
| All-time high | $282.0417 (Jun 10, 2026) |
| All-time low | $217.3913 (Jun 17, 2020) |
| 52-week high | $282.0417 |
| 52-week low | $276.3138 |
| Median price | $251.8531 |
| Average price | $249.0555 |
| Largest weekly change | +5.9% (Feb 2, 2022) |
| Weeks tracked | 388 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPATHA 140 MG/ML SURECLICK?
The current National Average Drug Acquisition Cost (NADAC) for REPATHA 140 MG/ML SURECLICK, manufactured by Amgen Inc., is $282.0209 per ML (NDC 72511076002), effective Jun 24, 2026.
How has the price of REPATHA 140 MG/ML SURECLICK changed over time?
Over the history we have for it, the NADAC for REPATHA 140 MG/ML SURECLICK has risen 29.2%. It has been tracked across 388 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for REPATHA 140 MG/ML SURECLICK?
Since Jan 23, 2019, the NADAC for REPATHA 140 MG/ML SURECLICK has ranged from a low of $217.3913 (Jun 17, 2020) to a high of $282.0417 (Jun 10, 2026), with a median of $251.8531 per ML.
Are there cheaper alternatives to REPATHA 140 MG/ML SURECLICK?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, REPATHA 140 MG/ML SYRINGE, is $281.6973 per ML — about 0% below REPATHA 140 MG/ML SURECLICK.
Who manufactures REPATHA 140 MG/ML SURECLICK?
REPATHA 140 MG/ML SURECLICK (NDC 72511076002) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification